Aroflo (Salmeterol & Fluticasone Propionate)
Therapeutic Group : Inhaler Indications: Aroflo HFA inhaler is indicated in the regular treatment of asthma where use of a combination product (long-acting ß2-agonist and inhaled corticosteroid) is appropriate: 1. patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short acting ß2-agonist or 2. patients already adequately controlled on both inhaled corticosteroid and […]